Prevention of hepatitis C virus infection.
Despite the promising progress made in the development of experimental HCV hyperimmune globulin preparations and recombinant vaccines, prevention of HCV infection will continue to be an important research front for many years. Until effective and safe immunoprophylaxis is available, preventive efforts will require further understanding of risk factors associated with infection and implementation of strategies to reduce such exposures.
Koff
R S
RS
University of Massachusetts Medical School, Framingham, Massachusetts 01702, USA.
D006526:Hepatitis C / Q000276:immunology / Q000517:prevention & control* / Q000635:transmission; D019698:Hepatitis C, Chronic / Q000276:immunology / Q000517:prevention & control*; D007114:Immunization; D007136:Immunoglobulins / Q000276:immunology; D040242:Risk Reduction Behavior; D015819:Substance Abuse, Intravenous / Q000821:virology; D065227:Transfusion Reaction; D014761:Viral Hepatitis Vaccines / Q000276:immunology / Q000627:therapeutic use*
D007136:Immunoglobulins; D014761:Viral Hepatitis Vaccines